Hi-Tech Pharmacal has announced that the FDA has granted final approval to the company's abbreviated new drug application for ciclopirox topical solution, 8%.
Subscribe to our email newsletter
Hi-Tech’s ciclopirox topical solution is the generic equivalent of Dermik Laboratories’ nail fungus treatment penlac topical solution, which had sales of $87 million in 2006 based on IMS sales data.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.